Advanced search
1 file | 255.09 KB Add to list

Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study

Author
Organization
Keywords
:Critically ill patients, Continuous infusion, Target attainment, Piperacillin, Meropenem, Empirical therapy, AUGMENTED RENAL CLEARANCE, AUSTRALIAN INDIGENOUS PATIENTS, BETA-LACTAM ANTIBIOTICS, PHARMACOKINETICS, SEPSIS, INTERMITTENT, TISSUE, BOLUS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 255.09 KB

Citation

Please use this url to cite or link to this publication:

MLA
Dhaese, Sofie, et al. “Early Target Attainment of Continuous Infusion Piperacillin/Tazobactam and Meropenem in Critically Ill Patients : A Prospective Observational Study.” JOURNAL OF CRITICAL CARE, vol. 52, 2019, pp. 75–79, doi:10.1016/j.jcrc.2019.04.013.
APA
Dhaese, S., Thooft, A., Farkas, A., Lipman, J., Verstraete, A., Stove, V., … De Waele, J. (2019). Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study. JOURNAL OF CRITICAL CARE, 52, 75–79. https://doi.org/10.1016/j.jcrc.2019.04.013
Chicago author-date
Dhaese, Sofie, Alexander Thooft, Andras Farkas, Jeffrey Lipman, Alain Verstraete, Veronique Stove, Jason A. Roberts, and Jan De Waele. 2019. “Early Target Attainment of Continuous Infusion Piperacillin/Tazobactam and Meropenem in Critically Ill Patients : A Prospective Observational Study.” JOURNAL OF CRITICAL CARE 52: 75–79. https://doi.org/10.1016/j.jcrc.2019.04.013.
Chicago author-date (all authors)
Dhaese, Sofie, Alexander Thooft, Andras Farkas, Jeffrey Lipman, Alain Verstraete, Veronique Stove, Jason A. Roberts, and Jan De Waele. 2019. “Early Target Attainment of Continuous Infusion Piperacillin/Tazobactam and Meropenem in Critically Ill Patients : A Prospective Observational Study.” JOURNAL OF CRITICAL CARE 52: 75–79. doi:10.1016/j.jcrc.2019.04.013.
Vancouver
1.
Dhaese S, Thooft A, Farkas A, Lipman J, Verstraete A, Stove V, et al. Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study. JOURNAL OF CRITICAL CARE. 2019;52:75–9.
IEEE
[1]
S. Dhaese et al., “Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study,” JOURNAL OF CRITICAL CARE, vol. 52, pp. 75–79, 2019.
@article{8613415,
  author       = {{Dhaese, Sofie and Thooft, Alexander and Farkas, Andras and Lipman, Jeffrey and Verstraete, Alain and Stove, Veronique and Roberts, Jason A. and De Waele, Jan}},
  issn         = {{0883-9441}},
  journal      = {{JOURNAL OF CRITICAL CARE}},
  keywords     = {{:Critically ill patients,Continuous infusion,Target attainment,Piperacillin,Meropenem,Empirical therapy,AUGMENTED RENAL CLEARANCE,AUSTRALIAN INDIGENOUS PATIENTS,BETA-LACTAM ANTIBIOTICS,PHARMACOKINETICS,SEPSIS,INTERMITTENT,TISSUE,BOLUS}},
  language     = {{eng}},
  pages        = {{75--79}},
  title        = {{Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients : a prospective observational study}},
  url          = {{http://dx.doi.org/10.1016/j.jcrc.2019.04.013}},
  volume       = {{52}},
  year         = {{2019}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: